What happens when the cellular machinery making therapeutic proteins slows down? New research in Nature shows why translation ...

An experimental synthetic non-coding RNA drug has reversed signs of systemic sclerosis in patient-derived immune cells and mouse models, with researchers now preparing an IND application to the FDA.

A £20 million high-security facility in Liverpool is set to accelerate drug and vaccine discovery by integrating artificial ...

UK genomics and drug discovery company OutSee has received £50,000 in Innovate UK funding to develop an agentic AI sub-system ...

A compound originally designed to block a cancer-associated protein has demonstrated unexpected benefits for bone health and ...

A new NIH-funded study suggests the GLP-1 receptor agonist semaglutide may slow biological ageing and extend lifespan in ...

Whole-genome sequencing of parasites from Ugandan patients has uncovered a cluster of genetic variants linked to reduced ...

The global oligonucleotide CDMO market is projected to nearly triple in value to USD 11.14 billion by 2031, driven by rising ...

A preclinical study has identified lysyl oxidase as an intracellular survival factor in triple-negative breast cancer, with ...

Insilico Medicine has unveiled a suite of compact, domain-trained AI models targeting ADMET prediction, retrosynthesis and ...

A metabolic signal detectable in patient blood has been linked to ALS progression rate and survival, with preclinical data ...

As NAMs become more widely used in drug discovery, assays must meet the demands of more complex models. Discover six ...